anmelden
SMI
13.172,10
PKT
-111,16
PKT
-0,84
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.05.22 | Zurich Insurance Overweight | Barclays Capital | |
| 10.05.22 | Zurich Insurance Overweight | JP Morgan Chase & Co. | |
| 09.05.22 | Nestlé Buy | Goldman Sachs Group Inc. | |
| 06.05.22 | Swiss Re Hold | Deutsche Bank AG | |
| 06.05.22 | Swiss Re Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.05.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.05.22 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 05.05.22 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 04.05.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 02.05.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 02.05.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 29.04.22 | UBS Sector Perform | RBC Capital Markets | |
| 28.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 28.04.22 | UBS Hold | Deutsche Bank AG | |
| 28.04.22 | ABB (Asea Brown Boveri) Outperform | RBC Capital Markets | |
| 28.04.22 | UBS Underweight | Barclays Capital | |
| 28.04.22 | UBS Neutral | UBS AG | |
| 28.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.22 | Holcim Hold | Deutsche Bank AG | |
| 28.04.22 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 27.04.22 | Richemont Buy | HSBC | |
| 27.04.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.04.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 27.04.22 | UBS Outperform | Credit Suisse Group | |
| 27.04.22 | Novartis Neutral | Credit Suisse Group | |
| 27.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 27.04.22 | UBS Buy | Deutsche Bank AG | |
| 27.04.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 27.04.22 | Novartis Neutral | UBS AG | |
| 27.04.22 | Novartis Sell | Deutsche Bank AG | |
| 27.04.22 | UBS Sector Perform | RBC Capital Markets | |
| 27.04.22 | UBS Outperform | RBC Capital Markets | |
| 27.04.22 | UBS Hold | Jefferies & Company Inc. | |
| 27.04.22 | ABB (Asea Brown Boveri) Outperform | Bernstein Research | |
| 27.04.22 | UBS Underweight | Barclays Capital | |
| 27.04.22 | UBS Equal Weight | Barclays Capital | |
| 26.04.22 | Novartis Neutral | UBS AG | |
| 26.04.22 | Roche Neutral | Credit Suisse Group | |
| 26.04.22 | Roche Buy | Deutsche Bank AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.